0
Your cart

Your cart is empty

Books > Business & Economics > Business & management > Management & management techniques > Organizational theory & behaviour

Buy Now

The Global Pharmaceutical Industry - The Demise and the Path to Recovery (Hardcover) Loot Price: R4,134
Discovery Miles 41 340
The Global Pharmaceutical Industry - The Demise and the Path to Recovery (Hardcover): Daniel Hoffman, Allan Bowditch

The Global Pharmaceutical Industry - The Demise and the Path to Recovery (Hardcover)

Daniel Hoffman, Allan Bowditch

Series: Routledge Advances in Management and Business Studies

 (sign in to rate)
Loot Price R4,134 Discovery Miles 41 340 | Repayment Terms: R387 pm x 12*

Bookmark and Share

Expected to ship within 12 - 17 working days

The pharmaceutical industry, long thought of as a recession-proof investment, now faces a day of reckoning. The reasons for this impending downfall are not hard to discern. The prices the industry charges for its prescription drugs have escalated at four to five times the cost-of-living increases during the past two decades and have reached a point where 30% of Americans must choose between filling a prescription, paying for housing, and buying food. This has brought about public pressure on governments around the world to control drug prices, yet the world's twenty largest pharma companies realized 80% of their growth as a result of exorbitant price hikes. Pharma currently enjoys its extraordinary profitability by exploiting the world's most vulnerable populations. Yet even their ability to increase prices in the face of falling demand does not satisfy their profit demands. The breadth and depth of pharma's marketing transgressions exceed those of any other industry and have now reached a point where authorities around the world have found it necessary to take legal action against its violations. Drastic change is needed if the pharmaceutical industry can equitably advance the health of the world's population and regain public esteem. This book illustrates the range and extent of pharma's violations and addresses the actions that should be implemented in order to make the drug industry a more constructive, less venal part of contemporary society. It will be of interest to researchers, academics, practitioners, and students with an interest in the pharmaceutical industry, healthcare management, regulation, and bioethics.

General

Imprint: Routledge
Country of origin: United Kingdom
Series: Routledge Advances in Management and Business Studies
Release date: July 2020
First published: 2021
Authors: Daniel Hoffman • Allan Bowditch
Dimensions: 229 x 152 x 16mm (L x W x T)
Format: Hardcover
Pages: 130
ISBN-13: 978-0-367-48551-1
Categories: Books > Business & Economics > Business & management > Business strategy
Books > Social sciences > Sociology, social studies > Social institutions > General
Books > Business & Economics > Business & management > Management & management techniques > Organizational theory & behaviour
Books > Business & Economics > Business & management > Management of specific areas > General
Books > Business & Economics > Business & management > Sales & marketing > Market research
Books > Business & Economics > Industry & industrial studies > Manufacturing industries > Pharmaceutical industries
Books > Law > Jurisprudence & general issues > Foundations of law > General
Books > Medicine > General issues > Health systems & services > General
Books > Law > Laws of other jurisdictions & general law > Private, property, family law > Personal property law > Intellectual property, copyright & patents
LSN: 0-367-48551-6
Barcode: 9780367485511

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners